-
VaxGen on the brink after FDA puts a clinical hold on anthrax vaccine
Concerned about stability, FDA tells VaxGen to hold off on phase 2 testing; Health and Human Services looks ready to terminate $877 million contract; with $50 million in cash on hand but no revenue stream, company stock plunges in Friday trading
-
-
Cornell scientists fight back against Hendra and Nipah viruses
Emerging technique inhibits the zoonotic viruses from binding to human cells; both Hendra and Nipah are seen as potential bioweapons
-
-
CA spinach and lettuce industry volunteers itself for regulatory oversight
Worried about flagging consumer confidence, the Western Growers Association asks state health officials to pass tougher food safety rules; proposed penalties could include injunctions against sale and criminal prosecution
-
-
-
-
WHO challenges China over new bird flu strain
Government denies emergence of new strain, but WHO and other authorities disagree; information sharing at issue; WHO hopes China will soon agree to upload gene sequences to a public data base
-
-
Salmonella outbreak prompts a review of detection and food safety products
We take a look back on our reporting for the year and offer readers a close look at some innovative approaches; Warnex receives CDC approval for detection system; Department of Agriculture steps up inspection and reporting regimes; Alto-Shaam offers food monitoring technology
-
-
Expert says surgical masks a simple but effective pandemic response
As compared to respirators, citizens find surgical masks comfortable and would therefor be more likely to use them; aerosol transmission the leading cause of infection; price is 10 cents per unit, but enterprising firms should note that U.S. demand alone could reach 20 billion
-
-
Achaogen announces $24.7 million DTRA deal to combat anthrax and plague
Four-year deal with Defense Threat Reduction Agency will focus on inhibiting antibiotic-resistant strains; once weakened, bacteria are vulnerable to fluoroquinolones and other antibacterial drugs; deal comes in the wake of a succesfully completed Series B funding round
-
-
Listening in on bacteria “conversations” help in efforts to keep deadly infections in check
There may be a debate about the legality of eavesdropping by the NSA on U.S. phone conversation, but few would question listening in on conversations among bacteria – conversations carried out by chemical signals bacteria use to communicate with each other – because these conversations give us knowledge on how to block deadly infections
-
-
Judge allows Boston biosafety lab to continue construction
Level 4 facility will study deadly microbes such as ebola and anthrax, and so local residents are reasonably nervous; court allows NIH-sponsored program to continue while environmental and public health concerns are reevaluated; possibility left open for a future injunction
-
-
Biowarfare threat a business opportunity for laboratory industry
Planned expansion of secure bioweapons labs creates a demand for equipment; water testing devices a critical need; automated cyanide analyzers, total organic content, and purge-and-trap sample concentrators among other specialized tools
-
-
PharmAthene and Medarex receive DoD grant for anthrax treatment
Unlike antibiotics, the companies’ monoclonal antibody approach should be effective days after exposure; an effective attack will be surreptitious, so the need for long-term treatment is great
-
-
University of Minnesota seeks grant extension for food and bioterror efforts
National Center for Food Protection and Defense nears the end of a three year grant; center a leader in the field with innovative approaches in sensor and analytic technology, data management, and predictive software
-
-
Court delays opening of California bioterrorism defense lab, citing safety concerns
They say about some do-gooders that they love humanity — it is people they don’t like; the same with biodefense labs: Communities love the idea of more jobs, more money, and more development which these biodefense labs bring, they just don’t like the associated safety risks; in the latest case, a court puts on hold the construction of a lab at Lawrence Livermore
-
More headlines
The long view
Mathematical Models Tackle Covid Infection Dynamics
Even years after the emergence of the COVID-19 global pandemic, the workings of SARS-CoV-2 infection inside the human body, including the early activity of the virus and the role of the body’s immune response, has proved difficult to precisely ascertain.